Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vonoprazan vs esomeprazole in bismuth-containing quadruple therapy for Helicobacter pylori eradication
CTR20190967Phase 3Completed
- Sponsor
- Takeda
- Start
- Dec 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of vonoprazan in Helicobacter pylori infection, sponsored by Takeda. Started Dec 2019; status: completed.
02
Drugs
vonoprazan
03
Conditions
Helicobacter pylori infection
Beyond the preview
Go deeper on CTR20190967.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20190967.